Role of Gross Tumor Volume in the Prognosis of Non-small Cell Lung Cancer Treated With 3D Conformal Radiotherapy: A Meta-analysis

被引:12
作者
Yu, Yang [1 ]
Guan, Hui [1 ]
Xing, Li-Gang [2 ,3 ]
Xiang, Yong-Bing [4 ]
机构
[1] Shandongs Key Lab Radiat Oncol, Dept Radiat Oncol, Jinan, Peoples R China
[2] Univ Jinan, Sch Med & Life Sci, Shandong Canc Hosp & Inst, Dept Oncol, Jinan, Peoples R China
[3] Shandong Acad Med Sci, Jinan, Peoples R China
[4] Shanghai Jiao Tong Univ, Renji Hosp, Dept Oncol, Shanghai 200030, Peoples R China
关键词
3D conformal radiotherapy; gross tumor volume; meta-analysis; non-small cell lung cancer; RADIATION-THERAPY; STAGE-III; 4-DIMENSIONAL CT; PUBLICATION BIAS; SURVIVAL; CARCINOMA; HETEROGENEITY; CHEMORADIOTHERAPY; CHEMOTHERAPY; PROGRESSION;
D O I
10.1016/j.clinthera.2015.07.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Three-dimensional conformal radiotherapy (3D-CRT) has become widely applied in patients with non small cell lung cancer (NSCLC), and gross tumor volume (GTV) is a reliable index for predicting prognosis in patients with NSCLC. This meta-analysis investigated the association between GTV and prognosis in patients with NSCLC after 3D-CRT. Methods: Electronic bibliographic databases were searched to identify articles related to NSCLC and 3D-CRT. The search results were carefully screened, using predetermined selection criteria, to select the most relevant studies. Newcastle-Ottawa Scale criteria were applied by 2 reviewers independently to evaluate the quality of the methodology of each included article., Based on GTV, each patient was assigned to either the study group (large GTV [>= 112 cm(3)]) or the control group (small GTV [<112 cm(3)]), and the mean rates of overall survival (OS) and survival at 1, 3, and 5 years were calculated in each group. Summary hazard ratio (HR) with 95% CI was calculated. Findings: The data from 10 cohort studies were incorporated into the current meta-analysis (1473 patients; study group, 773; control group, 700). The OS in the study group was significantly less than that in the control group (HR = 1.52; 95% CI, 1.10-1.94; P < 0.01). The study and control groups also had significantly different survival rates at 1 year (HR = 1.27; 95% CI, 1.10-1.46, P = 0.01), 3 years (HR = 2.06; 95% CI, 1.63-2.61; P < 0.01), and 5 years (HR = 2.25; 95% CI, 1.63-3.10; P < 0.01). Findings from funnel plots and Egger tests of the OS and 3-year survival rate suggested no publication bias. With respect to the 1- and 5-year survival rates, however, the funnel plots and Egger tests demonstrated publication bias among the included studies. Implications: The relatively small number of studies and small sample size, as well as the lack of a specific and standard method of defining small and large GTV, may have influenced the credibility and reliability of our results. The findings suggest that GTV influences prognosis in patients with NSCLC after 3DCRT. However, further studies with larger sample sizes are needed to confirm our finding that a larger GTV is negatively associated with NSCLC prognosis after 3D-CRT. (C) 2015 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:2256 / 2266
页数:11
相关论文
共 43 条
[1]   Cooperative Regulation of Non-Small Cell Lung Carcinoma by Nicotinic and Beta-Adrenergic Receptors: A Novel Target for Intervention [J].
Al-Wadei, Hussein A. N. ;
Al-Wadei, Mohammed H. ;
Schuller, Hildegard M. .
PLOS ONE, 2012, 7 (01)
[2]   Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure [J].
Andratschke, Nicolaus ;
Zimmermann, Frank ;
Boehm, Eva ;
Schill, Sabine ;
Schoenknecht, Christine ;
Thamm, Reinhard ;
Molls, Michael ;
Nieder, Carsten ;
Geinitz, Hans .
RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) :245-249
[3]   Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal [J].
Bazan, Jose G. ;
Koong, Albert C. ;
Kapp, Daniel S. ;
Quon, Andrew ;
Graves, Edward E. ;
Loo, Billy W., Jr. ;
Chang, Daniel T. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (01) :27-32
[4]   Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma [J].
Bradley, JD ;
Ieumwananonthachai, N ;
Purdy, JA ;
Wasserman, TH ;
Lockett, MA ;
Graham, MV ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01) :49-57
[5]   The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis [J].
Chen, Wen-Liang ;
Kuo, Kuang-Tai ;
Chou, Teh-Ying ;
Chen, Chien-Lung ;
Wang, Chih-Hao ;
Wei, Yau-Huei ;
Wang, Liang-Shun .
BMC CANCER, 2012, 12
[6]   Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer [J].
Cheruvu, Praveena ;
Metcalfe, Su K. ;
Metcalfe, Justin ;
Chen, Yuhchyau ;
Okunieff, Paul ;
Milano, Michael T. .
RADIATION ONCOLOGY, 2011, 6
[7]  
[崔彦莉 CUI Yanli], 2009, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V36, P605
[8]   Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer [J].
De Petris, L ;
Lax, I ;
Sirzén, F ;
Friesland, S .
MEDICAL ONCOLOGY, 2005, 22 (04) :375-381
[9]   High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer [J].
De Ruysscher, Dirk ;
Faivre-Finn, Corinne ;
Le Pechoux, Cecile ;
Peeters, Stephanie ;
Belderbos, Jose .
LANCET ONCOLOGY, 2014, 15 (13) :E620-E624
[10]   Associations of Polymorphisms in DNA Repair Genes and MDR1 Gene with Chemotherapy Response and Survival of Non-Small Cell Lung Cancer [J].
Du, Yan ;
Su, Tong ;
Zhao, Lijun ;
Tan, Xiaojie ;
Chang, Wenjun ;
Zhang, Hongwei ;
Cao, Guangwen .
PLOS ONE, 2014, 9 (06)